Andrew J. Head
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andrew J. Head has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Aaron T Eggebeen
Department of Medicine, Rheumatology, Michigan State University, College of Human Medicine Grand Rapids, Grand Rapids, MI 49546, USA
1 shared publication - Donald J. Tellinghuisen
Calvin College, Grand Rapids, MI, USA
1 shared publication - James D Birmingham
Department of Medicine, Rheumatology, Michigan State University, College of Human Medicine Grand Rapids, Grand Rapids, MI 49546, USA
1 shared publication Jeffrey D. Thompson
University of Tennessee Health Science Center and Children's Foundation Research Center at LeBonheur Children's Medical Center, Memphis, Tennessee
1 shared publication- Kelsey McCallops
Department of Psychology, Calvin College Grand Rapids, Grand Rapids, MI 49546, USA
1 shared publication Linda K. Myers
University of Tennessee Health Science Center and Children's Foundation Research Center at LeBonheur Children's Medical Center, Memphis, Tennessee
1 shared publication
Latest Publications
- Open Access
- 12 August 2013
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 13 (1) , 89
Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug
The causes of the underutilization of disease modifying anti-rheumatic drugs (DMARDS) for rheumatoid arthritis (RA) are not fully known, but may in part, relate to individual patient factors including risk perception. Our objective was to identify the determinants of risk perception (RP) in RA patients and predictors of their willingness to take a proposed DMARD (DMARD willingness).
- 12 August 2013
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 13 (1) , 89
Open AccessInfluence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug
The causes of the underutilization of disease modifying anti-rheumatic drugs (DMARDS) for rheumatoid arthritis (RA) are not fully known, but may in part, relate to individual patient factors including risk perception. Our objective was to identify the determinants of risk perception (RP) in RA patients and predictors of their willingness to take a proposed DMARD (DMARD willingness).
- 15 February 2005
- Published by Wiley in Arthritis & Rheumatism
- Vol. 53 (1) , 138-141
Disseminated blastomycosis presenting as oligoarticular septic arthritis in a 12-year-old girl
- 15 February 2005
- Published by Wiley in Arthritis & Rheumatism
- Vol. 53 (1) , 138-141
Disseminated blastomycosis presenting as oligoarticular septic arthritis in a 12-year-old girl